vs
BALCHEM CORP（BCPC）与Tilray Brands, Inc.（TLRY）财务数据对比。点击上方公司名可切换其他公司
BALCHEM CORP的季度营收约是Tilray Brands, Inc.的1.2倍（$270.7M vs $217.5M），BALCHEM CORP净利率更高（14.9% vs -20.7%，领先35.5%），BALCHEM CORP同比增速更快（8.1% vs 3.1%），过去两年BALCHEM CORP的营收复合增速更高（7.5% vs 7.5%）
Balchem Corp是一家全球特种化学品与营养原料供应商，核心业务覆盖人类营养、动物保健、制药、工业应用四大领域，为北美、欧洲、亚太等地区的客户提供定制化专用原料产品。
Tilray Brands, Inc.是一家美国企业，主营医药、大麻生活方式产品以及包装消费品业务，公司注册于美国，总部坐落于纽约。该公司在加拿大、澳大利亚、新西兰、拉美地区均开展业务，同时在德国和葡萄牙拥有大麻种植基地。
BCPC vs TLRY — 直观对比
营收规模更大
BCPC
是对方的1.2倍
$217.5M
营收增速更快
BCPC
高出5.0%
3.1%
净利率更高
BCPC
高出35.5%
-20.7%
两年增速更快
BCPC
近两年复合增速
7.5%
损益表 — Q1 FY2026 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $270.7M | $217.5M |
| 净利润 | $40.3M | $-44.9M |
| 毛利率 | — | 26.4% |
| 营业利润率 | 20.5% | -10.2% |
| 净利率 | 14.9% | -20.7% |
| 营收同比 | 8.1% | 3.1% |
| 净利润同比 | 8.7% | 47.4% |
| 每股收益（稀释后） | $1.25 | $-0.41 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BCPCTLRY
| Q1 26 | $270.7M | — | ||
| Q4 25 | $263.6M | $217.5M | ||
| Q3 25 | $267.6M | $209.5M | ||
| Q2 25 | $255.5M | $224.5M | ||
| Q1 25 | $250.5M | $185.8M | ||
| Q4 24 | $240.0M | $210.9M | ||
| Q3 24 | $239.9M | $200.0M | ||
| Q2 24 | $234.1M | $229.9M |
净利润BCPCTLRY
| Q1 26 | $40.3M | — | ||
| Q4 25 | $39.2M | $-44.9M | ||
| Q3 25 | $40.3M | $-322.0K | ||
| Q2 25 | $38.3M | $-1.3B | ||
| Q1 25 | $37.1M | $-789.4M | ||
| Q4 24 | $33.6M | $-85.3M | ||
| Q3 24 | $33.8M | $-39.2M | ||
| Q2 24 | $32.1M | $-31.7M |
毛利率BCPCTLRY
| Q1 26 | — | — | ||
| Q4 25 | 35.6% | 26.4% | ||
| Q3 25 | 35.7% | 27.4% | ||
| Q2 25 | 36.4% | 30.1% | ||
| Q1 25 | 35.2% | 28.0% | ||
| Q4 24 | 36.0% | 29.0% | ||
| Q3 24 | 35.6% | 29.8% | ||
| Q2 24 | 35.5% | 35.8% |
营业利润率BCPCTLRY
| Q1 26 | 20.5% | — | ||
| Q4 25 | 19.8% | -10.2% | ||
| Q3 25 | 20.4% | 1.0% | ||
| Q2 25 | 20.1% | -643.1% | ||
| Q1 25 | 20.4% | -409.0% | ||
| Q4 24 | 19.8% | -20.0% | ||
| Q3 24 | 20.0% | -18.3% | ||
| Q2 24 | 19.6% | -7.2% |
净利率BCPCTLRY
| Q1 26 | 14.9% | — | ||
| Q4 25 | 14.9% | -20.7% | ||
| Q3 25 | 15.1% | -0.2% | ||
| Q2 25 | 15.0% | -566.9% | ||
| Q1 25 | 14.8% | -424.9% | ||
| Q4 24 | 14.0% | -40.5% | ||
| Q3 24 | 14.1% | -19.6% | ||
| Q2 24 | 13.7% | -13.8% |
每股收益（稀释后）BCPCTLRY
| Q1 26 | $1.25 | — | ||
| Q4 25 | $1.21 | $-0.41 | ||
| Q3 25 | $1.24 | $0.00 | ||
| Q2 25 | $1.17 | $7.26 | ||
| Q1 25 | $1.13 | $-8.69 | ||
| Q4 24 | $1.03 | $-0.99 | ||
| Q3 24 | $1.03 | $-0.04 | ||
| Q2 24 | $0.98 | $-0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $72.9M | $291.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.3B | $1.6B |
| 总资产 | $1.7B | $2.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BCPCTLRY
| Q1 26 | $72.9M | — | ||
| Q4 25 | $74.6M | $291.6M | ||
| Q3 25 | $65.1M | $264.8M | ||
| Q2 25 | $65.4M | $256.4M | ||
| Q1 25 | $49.9M | — | ||
| Q4 24 | $49.5M | $252.2M | ||
| Q3 24 | $73.7M | $280.1M | ||
| Q2 24 | $63.7M | $260.5M |
股东权益BCPCTLRY
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $1.6B | ||
| Q3 25 | $1.3B | $1.5B | ||
| Q2 25 | $1.3B | $1.5B | ||
| Q1 25 | $1.2B | $2.7B | ||
| Q4 24 | $1.1B | $3.5B | ||
| Q3 24 | $1.2B | $3.5B | ||
| Q2 24 | $1.1B | $3.4B |
总资产BCPCTLRY
| Q1 26 | $1.7B | — | ||
| Q4 25 | $1.7B | $2.1B | ||
| Q3 25 | $1.7B | $2.1B | ||
| Q2 25 | $1.7B | $2.1B | ||
| Q1 25 | $1.6B | — | ||
| Q4 24 | $1.6B | $4.2B | ||
| Q3 24 | $1.6B | $4.3B | ||
| Q2 24 | $1.6B | $4.2B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $40.1M | $-8.5M |
| 自由现金流经营现金流 - 资本支出 | $33.8M | — |
| 自由现金流率自由现金流/营收 | 12.5% | — |
| 资本支出强度资本支出/营收 | 2.3% | — |
| 现金转化率经营现金流/净利润 | 0.99× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流BCPCTLRY
| Q1 26 | $40.1M | — | ||
| Q4 25 | $67.3M | $-8.5M | ||
| Q3 25 | $65.6M | $-1.3M | ||
| Q2 25 | $47.3M | $-12.8M | ||
| Q1 25 | $36.5M | $-5.8M | ||
| Q4 24 | $52.3M | $-40.7M | ||
| Q3 24 | $51.3M | $-35.3M | ||
| Q2 24 | $45.0M | $30.7M |
自由现金流BCPCTLRY
| Q1 26 | $33.8M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $-19.1M | ||
| Q1 25 | — | $-20.2M | ||
| Q4 24 | — | $-46.2M | ||
| Q3 24 | — | $-42.0M | ||
| Q2 24 | — | $21.0M |
自由现金流率BCPCTLRY
| Q1 26 | 12.5% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -8.5% | ||
| Q1 25 | — | -10.9% | ||
| Q4 24 | — | -21.9% | ||
| Q3 24 | — | -21.0% | ||
| Q2 24 | — | 9.1% |
资本支出强度BCPCTLRY
| Q1 26 | 2.3% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 2.8% | ||
| Q1 25 | — | 7.8% | ||
| Q4 24 | — | 2.6% | ||
| Q3 24 | — | 3.4% | ||
| Q2 24 | — | 4.2% |
现金转化率BCPCTLRY
| Q1 26 | 0.99× | — | ||
| Q4 25 | 1.72× | — | ||
| Q3 25 | 1.63× | — | ||
| Q2 25 | 1.23× | — | ||
| Q1 25 | 0.98× | — | ||
| Q4 24 | 1.56× | — | ||
| Q3 24 | 1.52× | — | ||
| Q2 24 | 1.40× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BCPC
暂无分部数据
TLRY
| Adultuse Cannabis Products | $62.4M | 29% |
| Other | $59.2M | 27% |
| Beverage Alcohol Business | $53.6M | 25% |
| International Cannabis Products | $20.2M | 9% |
| Wellness Business | $14.6M | 7% |
| Medical Cannabis Products | $6.2M | 3% |
| Wholesale Cannabis Products | $1.3M | 1% |
